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The crystal structures of two new isomorphous 
pyridine structures, 2-ethoxy-4-(2-flurophenyl)-
5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-
carbonitrile (Ia) and 2-methoxy-4-(4-isopropylphenyl)-
5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-
carbonitrile (Ib) were elucidated by single crystal X 
ray diffraction. Compound (Ia) C20H21FN2O, crystalliz-
es in the monoclinic system, space group P21/n with a 
= 7.0738 (3) Å, b = 17.3519(8) Å, c = 14.4239 (7) Å, b 
= 91.837 (2)° and Z = 4. The compound (Ib), 
C22H25N2O, crystallizes in the same crystal system as 
compound (Ib), space group P21/c with a = 9.7123(6) 
Å, b = 20.6046(9) Å, c = 10.4657(6) Å,  b = 117.208 
(3)° and Z = 4. The central heterocyclic ring adopts a 
planar conformation and the cyclooctane ring adopts a 
twisted boat chair conformation in both (Ia) and (Ib).   
The synthesized compounds were screened for their 
anti-tuberculosis activity and were used to identify 
lead structures through docking studies, by automated 
docking. This approach was used to determine the ori-
entation of inhibitors bound in the active site with the 
enzyme N-acetyl-gamma-glutamyl-phosphate reduc-
tase that is involved in arginine biosynthesis in M. tu-
berculosis (MtbAGPR). Details of the preparation, 
crystal structure determination, intra and inter molecu-
lar interactions of the compounds and their docking 
studies are given.  
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Introduction 
 
Tuberculosis (TB) remains a deadly disease and con-
tinues to claim approximately 2 million lives annually. 
In affected regions, the disease is recognized as serious 
impediment to economic and social development. The 
prevalence of TB has been increasing, and presently 
nearly two billion individuals worldwide have been 
exposed to the tubercle bacillus. According to World 
Health Organization (WHO), roughly one-third of the 
world population is infected with Mtb (Granich et al. 
2003). Multi-drug resistance and the existence of a 
large reservoir of latently infected people pose a major 
threat. Moreover, alternate drugs are very much essen-
tial, in addition to the first line drugs normally used to 
treat TB infection because of the inefficacy of the lat-
ter in multi-drug resistant (MDR-TB) and extensive 
drug-resistant strains (XDR-TB). Also, the treatment 
regimen for XDR-TB infection usually takes two 
years. 
 Pyridine compounds, by large, reveal good 
anti-mycobacterial activities. Compounds (Ia) and (Ib), 
belong to the 2-pyridine class of compounds, which 
show a wide spectrum of biological activities (Perez-
Medina et al. 1947). It has been reported that the ison-
icotinic acid (INA) analog of nicotinamide adenine 
diphosphate (NAD) acts by disturbing the normal cel-
lular metabolism, probably due to its inability to par-
ticipate in redox reactions. This metabolic disturbance 
by isoniazid (INH) or INA apparently leads to the 
breakdown of mycolic acid synthesis and damage to 
the cell wall structure, as evidenced by the loss of 
‗‗acid-fastness‘‘ of mycobacteria carboxylate anions 
by enzymatic hydrolysis (Goldman 1954, Kaplan et al. 
1956, Winder et al. 1969). New 1,4-dihydropyridines 
bearing lipophilic groups in the ring were synthesized 
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Figure 1. Chemical diagram of the molecule (Ia) (left) and 
(Ib) (right).  
 
and evaluated for anti-tuberculosis activity upon the 
assumption that these compounds could act as pro-
drugs, and after penetration into the cell wall, would be 
converted into the 3,5-carboxylate anions by enzymat-
ic hydrolysis (Desai et al. 2001).  N-Alkyl-1,2-dihydro
-2-thioxo-3-pyridinecarbothioamides 2.18. N-
Pyridinylsalicylamides have been identified as a novel 
pyridine class of compounds with anti-tuberculosis 
activity (Ubiali et al. 2002).  In the course of screening 
for the discovery of new compounds that could be use-
ful for the treatment of TB, we report the synthesis and 
single crystal X-ray studies of two novel spiro com-
pounds, (Ia) and (Ib) (Figure 1), together with docking 
studies. 
 
Synthesis 
 
Preparation of compound (Ia) 
A mixture of cyclooctanone (1 mmol), 2- fluro benzal-
dehyde (1 mmol) and malononitrile (1mmol) were tak-
en in ethanol (10 mL) to which lithium ethoxide   (1 
equiv) was added. The reaction mixture was heated 
under reflux for 2–3 h. After completion of the reac-
tion (TLC), the reaction mixture was poured into 
crushed ice and extracted with ethyl acetate. The ex-
cess solvent was removed under vacuum and the resi-
due was subjected to column chromatography using a 
petroleum ether/ethyl acetate mixture (95:5 v/v) as elu-
ent to obtain the pure product. The melting point was 
99–101°C and yield 66%. 
 
Preparation of compound (Ib) 
A mixture of cyclooctanone (1 mmol), 4-isopropyl 
benzaldehyde (1 mmol) and malononitrile (1mmol) 
were taken in methanol (10 mL) to which lithium eth-
oxide (1 equiv) was added. The reaction mixture was 
heated under reflux for 2–3 h. After completion of the 
reaction (TLC), the reaction mixture was poured into 
crushed ice and extracted with ethyl acetate. The ex-
cess solvent was removed under vacuum and the resi-
due was subjected to column chromatography using a 
petroleum ether/ethyl acetate mixture (95:5 v/v) as elu-
ent to obtain the pure product. The melting point was 
160–161°C and yield 75%. 
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Table 1. The crystal data, experimental conditions and structure refinement parameters of the compound (Ia) and (Ib).  
Empirical formula C20H21FN2O, C22H25N2O 
Formula weight 324.4 334.5 
Temperature 293(2) K 293(2) K 
Wavelength 0.71073 Å 0.71073 Å 
Crystal system, space group P21/n, Monoclinic P 21/c,  monoclinic 
Unit cell dimensions 
a = 7.0738(3)Å,  
b=17.3519(8)Å 
c = 14.4239(7)Å, β=91.837(2)° 
a = 9.7123(6)Å, 
b =20.6046(12) Å, 
c = 10.4657(6)Å, β=117.208(3)° 
Volume  1769.54 (2) Å3 1862.64(3) A3 
Z, Calculated density 4,  1.22 mg/m3 4,  1.19 mg/m3 
Absorption coefficient 0.083 mm-1 0.073  mm-1 
F(000) 688 720 
Crystal size 0.19x0.16x0.14mm3 0.17x0.14x0.11mm3 
Theta range for data collection 2.3 to 26.1 deg 2 to 28.3 deg 
Limiting indices -8<=h<=8, -21,=k<=21, -17<=l<=17 -12<=h<12, -27<=k<18, -13<=l<=13 
Reflections collected / unique 16997 / 3516 [R(int) = 0.0308] 16998 / 4594[Rint = 0.0219] 
Completeness to theta 99.8 % 99.4% 
Absorption correction ω -scan ω -scan 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / parameters 3516 / 173 / 283 4594/ 3/ 251 
Goodness-of-fit on F2 1.036 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0489, wR2 = 0.1311 R1 = 0.0610, wR2 = 0.160 
R indices (all data) R1 = 0.0769, wR2 = 0.1503 R1 = 0.085, wR2 = 0.178 
Largest diff. peak and hole 0.185 and -0.197 eA-3 0.501  and  -0.335 eÅ -3 
Structure Determination and Refinement 
 
Intensity  data of the single crystal of the compounds 
were collected using a Bruker AXS Kappa APEX II 
single crystal CCD Diffractometer equipped with 
graphite-monochromated MoKα radiation 
(λ=0.71073Å) at room temperature. Accurate unit cell 
parameters were determined from the reflections of 36 
frames measured in three different crystallographic 
zones. The data collection, data reduction and absorp-
tion correction were performed by APEX2, SAINT-
Plus and SADABS (Bruker 2004). The structure was 
solved by the direct method procedure and the non-
hydrogen atoms were subjected to anisotropic refine-
ment by full-matrix least squares on F2 using SHELXL
-97 (Sheldrick 2008). Molecular graphics were drawn 
using PLATON (Spek 2009). The hydrogen atoms 
were placed in calculated positions and included in the 
refinement using the riding model with C—H = 0.93–
0.98 Å and Uiso = 1.2Ueq(C,N) for the CH and CH2 
groups and Uiso = 1.5Ueq(C) for the CH3 group. The 
crystal data, experimental conditions and structure re-
finement parameters for the compounds (Ia) and (Ib) 
are presented in Table 1. Their molecular structures, 
showing the atom numbering scheme using ORTEP 3 
(Farrugia 1997) are shown in Figure 2. The disordered 
model was refined using the tools available in 
SHELXL-97 (Sheldrick 2008) and SADI for restrain-
ing distances. A combination of SIMU (similar Uij 
parameters) and DELU (rigid bonds) restraints were 
applied (Sheldrick 2008). Also, a DFIX restraint was 
used to stabilize the refinement of the disordered at-
oms.  
 
Docking Studies 
 
Docking studies were carried out for the reported com-
pound with an enzyme involving arginine biosynthesis 
in Mtb. Arginine biosynthesis has been shown to be 
essential in Mtb. An ArgF mutant requiring exogenous 
L-arginine for growth in vitro has shown reduced viru-
lence in immunodeficient SCID mice and is highly 
attenuated in immune competent mice, suggesting that 
L-arginine availability is restricted in vivo (Gordhan et 
al. 2002). A recent study has identified ArgA, an es-
sential enzyme that catalyzes the conversion of L-
glutamate to a-N-acetyl-L-glutamate, as the  initial step 
in L-arginine biosynthesis (Errey et al. 2005). To 
begin with, high resolution of 1.8Å X-ray crystal struc-
tures of enzymes involved in arginine biosynthesis 
from Mtb were searched in the protein data bank 
(PDB).  
The search analysis showed that the X-ray 
crystal structure of N-acetyl-g-glutamyl phosphate re-
ductase from Mtb (MtbAGPR; PDB ID 2I3G) was 
identified as the suitable candidate for the docking 
studies. The corresponding coordinates of MtbAGPR 
were then retrieved from RCSB PDB. Moreover, for 
docking studies, only protein atoms were considered. 
The water oxygen atoms and other ligand atoms pre-
sent in the PDB file were removed using pyMOL 
(Delano 1998). It was solvated in a rectangular box of 
14,410 water molecules using the ―SPC216‖ model 
system in order to mimic the physiological behavior of 
the molecules. The energy of the solvated model was 
minimized without restraints for 1000 steps using the 
steepest descent algorithm which is followed by 1000 
steps of conjugate gradient algorithm. To minimize the 
ligand's energy for docking, MMFF94 force field with 
conjugate gradient algorithm was carried out in the 
OpenBabel platform of PyRx (Wolf 2009). The active 
site pocket of MtbAGPR was identified using online 
server Computed Atlas of Surface Topography 
(CASTp). Subsequently, the synthesized compound 
was docked at the active site identified by CASTp. 
Molecular docking of the compound with the 
protein molecule was carried out using the program 
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Figure 2. The molecular structure of compound (Ia) (left) and (Ib) (right), showing the atom numbering scheme. Displacement 
ellipsoids are drawn at 30% probability level, using ORTEP 3. Hydrogen atoms are drawn as spheres of arbitrary size.  
AutoDoCK4v2 (Goodsell 1998). A grid box of 76 x 62 
x 84 with the grid spacing of 0.375 Å was chosen. The 
grid was automatically centered at the middle of the 
active site. The electrostatic and atomic interaction 
maps for all atom types of the ligand molecule were 
calculated using the autogrid module of the AutoDock 
program. The Lamarckian genetic algorithm (LGA) 
was employed up to 100 runs for docking studies. The 
values and other parameters were taken as defaults in 
the docking program. The conformation of the docked 
ligand molecule was analyzed based on the binding 
energy values. 
The biological activity studies of the com-
pounds (Ia) and (Ib) are presently in progress. Apart 
from screening these compounds against MTB, their 
activity against antimicrobial and antifungal activities 
are also being done. 
 
Results and Discussion 
 
The molecular structures of (Ia) and (Ib) are shown in 
Figure 1. The cyclooctane ring in the two compounds 
adopts a twist boat chair conformation, as found in 
other related structures (Xiong et al. 2007, Fun et al. 
2010, Suresh et al. 2007). The central pyridine compo-
nent of (Ia) and (Ib) are effectively planar, with a max-
imum deviation from the mean plane that of -0.0132 
(4) Å for atom C10 of (Ia) and 0.0064 (1) Å for atom 
C8 of compound (Ib). This slight deviation may be 
associated with the presence of three adjacent substitu-
ents, at atoms C9 - C11. The deviation of the nitrile 
atoms (C12, N2) from the mean plane of the pyridine 
ring system (N1, C1, C8 - C11) is -0.0338 (6) Å and -
0.0622 (5) Å in compound (Ia), 0.0491 (8) Å and 
0.1179 (7) Å in compound (Ib). 
 The C4, C5 carbon atoms with their corre-
sponding hydrogen atoms of the cyclooctane ring and 
the fluoro-substituted benzene ring of compound (Ia) 
are statistically disordered over two conformations 
with a site-occupancy ratio of 0.554(8) : 0.446(8) (9) 
and 0.793 (2) : 0.207 (2), respectively. The C4, C5 
carbon atoms with their corresponding hydrogen atoms 
of cyclooctane ring of compound (Ib) are disordered 
with occupancy factors of 0.2242 (1) : 0.70379 (1), 
respectively. 
The triple-bond character of the C12 ≡ N2 
bond is 1.136 (3) Å and 1.138 (3) Å in compounds (Ia) 
and (Ib), respectively; this is similar to the other relat-
ed structures (Ramesh et al. 2009a, b) and the C10-
C12 ≡ N2 bond angle of 178.64(1)° and 178.40(1)°, 
defining the linearity of the cyano group are typical of 
this group of 2-oxopyridine-3-carbonitrile compounds 
(Black et al. 1992, Hussain et al. 1996). The carboni-
trile group lies almost in the plane of the attached pla-
nar pyridine ring system (N1, C1, C8-C11). The tor-
sion angles (C9-C10-C12-N2) and (C11-C10-C12-N2) 
define the orientation of the carbonitrile group with the 
pyridine ring (-152.59(6)° and 99.21(2)° in compounds 
(Ia) and (Ib) respectively and -28.30(6)° and                 
-78.81 (2)° in compounds (Ia) and (Ib) respectively). 
The bond distances in the central pyridine ring 
(C1/C8-C11/N1) range from 1.315(1) - 1.398 (2) Å in 
compound (Ia) and 1.313(1) - 1.401(2) Å in compound 
(Ib), suggesting possible resonance delocalization of 
the π electrons over the ring (Allen et al. 1987). The 
phenyl rings of the molecules are planar. Steric hin-
drances rotate the phenyl ring out of the plane of the 
central pyridine ring by 75.23 (8)°  and 73.67 (1)° in 
compound (Ia) and (Ib), respectively. These values are 
different from those in similar structures (Patel et al. 
2002a, Bolte 1998). 
The phenyl substituent at C9 of the pyridine 
ring has a (-) anticlinal conformation in compound (Ia) 
and (+) synclinal conformation in compound (Ib), 
which is evidenced by the  C96-C91-C9-C10 torsion 
angles -106.47(1) and 72.27(1)° in (Ia) and (Ib), re-
spectively. The ethoxy group in compounds (Ia) is co-
planar with the heterocyclic ring plane which is evi-
denced by the torsion angle C11-O1-C13-C14 = 
165.43 (2)° in (Ia). There is a long Csp2-Csp1 which is 
evidenced by the C10-C12 bond which is 1.425(2)Å 
and 1.436(2) Å in compounds (Ia) and (Ib), respective-
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Figure 3. Linear chain motif C1
1(6) of compound (Ia). 
Figure 4. A pair of inversely related molecules are intercon-
nected through C-H…π interaction of compound (Ia). 
ly. This is due to conjugation which has the similar 
orientation in similar related structures (Ramesh et al. 
2009a, b). 
 
Crystal Packing  
Both the structures differ in the nature of the substitu-
ents at the 2-position of the central pyridine ring and 
on the pendant aryl ring. This simple change in the 
structure substantially alters the intermolecular interac-
tion patterns. 
In the crystal structure of the compound (Ia), 
the C95 atom of the aryl ring is involved in the inter-
molecular interaction C95—H95···F1(i) with the F1 
atom forming a chain C1
1(6) motif (Bernstein et al. 
1995) around inversion centers of the unit cell. These 
motifs form a linear infinite double chain running 
along the a-axis as shown in Figure 3 [symmetry code: 
(i) 1+x, y, z]. In addition, the adjacent molecules are 
linked together by a  C—H…π(ii) interaction form-
ing a inversely related dimer (Figure 4) [symmetry 
code:  (ii) -x,-y,-z]. 
The crystal structure of the compound (Ib) 
contains a π···π interaction, Cg1···Cg1i (Cg1 is the 
centroid of the pyridine ring), with Cg1···Cg1i separa-
tion of 3.7625 (2) Å [symmetry code: (i) 1-x, -y, 1-z] 
as shown in Figure 5. Neither C-H…O nor C-H…p 
interactions are observed between these chains.  How-
ever, there are several van der Walls interactions be-
tween them in both compounds. Inter molecular and 
intra molecular hydrogen bond geometry of (Ia) is de-
tailed in Table 2. 
 
Docking Analysis 
The docking study was performed by automated dock-
ing and was used to determine the orientation of the 
inhibitors bound in the active site of MtbAGPR (PDB 
code: 2I3G) for antituberculosis. The target proteins 
had four identical chains, namely A, B, C and D, in the 
PDB file. However, only a monomer was chosen for 
analysis. Forty seven pockets were predicted using the 
Castp program. Of that, only one pocket was consid-
ered .This binding pocket was chosen on the basis of 
the presence of conserved catalytic residues such as 
Asp108, Arg114, Tyr211,His217, His219, Glu222, 
Asp319, Asn320, and Leu321, as well as six glycine 
residues (numbers 16,19, 157, 192, 249, 324) that have 
been reported in the literature (Cherney et al. 2007). 
Interestingly, this active site pocket was also the bind-
ing pocket for the NADP+ molecule. Thus, the biolog-
ically favorable site for docking was chosen. 
The docking of ligand molecules with 
MtbAGPR revealed that both inhibitor compounds ex-
hibited bonding with one or more amino acids (Table 
3) in the active pocket as shown in Figure 6. The study 
also revealed that the bipyridine scaffolds is the key 
residues at the active site of MtbAGPR. Moreover, 
both compounds have minimum binding energy hence 
could be considered as a good inhibitor of MtbAGPR. 
Between the compounds, (Ib) showed the highest bind-
ing energy score (Table 3). The ligands used for the 
docking studies showed similar modes of binding in-
teractions as that of the complex. Superimposition of 
the anti- biotics within the NADP+ molecule bind-
ing pocket indicates that the overlapping 
binding determinants are possible because 
of the remarkable correspondence in the 
overall shape of each antibiotic (Figure 8). 
These in silico results revealed that the 
synthesized bipyridine compounds may be 
an effective drug candidate for Mtb. 
 
Conclusion  
 
2-ethoxy-4-(2-flurophenyl)-5,6,7,8,9,10-
hexahydrocycloocta[b]pyridine-3-
Carbonitrile (Ia) and 2-methoxy-4-(4-
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Figure 5. A partial packing view of the compound (Ib) 
showing a pair of molecules interconnected through a π···π 
stacking interaction. 
D-H...A d(D-H) d(H...A) d(D...A) DHA 
C(95)-H(95)...F(1)(i) 0.93 2.52 3.2859(4) 
  
139 
  
C(13)-H(13B)...Cg1(ii) 0.93 2.89 3.8000(3) 157 
Table 2. Hydrogen bonds [Å and°] of compound (Ia).  
Symmetry transformations used to generate equivalent atoms: 
(i) 1+x, y, z 
(ii) -x,-y,-z 
isopropylphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]
pyridine-3-carbonitrile (Ib) were synthesized. The sin-
gle crystals of these compounds were obtained by the 
slow evaporation method with ethyl acetate as the sol-
vent. The structure determination of small molecules 
were carried out and discussed based on the physico-
chemical parameters as well as the earlier reports 
available in the literature. Molecular docking studies 
were performed with the suitable protein target. In ad-
dition, the orientation of the aryl rings can affect the 
alignment of these rings at a binding site and hence 
influence bioactivity (Quail et al. 2005). From the 
docking analysis of the two compounds with the recep-
tor of 2I3G, it was found that (Ib) shows better binding 
with the receptor, as compared to (Ia), with the energy 
of -7.55 kcal/mol. However, since there is very small 
change in the binding energy, both compounds can be 
used for the inhibition of 2I3G. 
 The theoretical outcome of the docking studies 
highlighted that the minimum binding energy of the 
molecules with the target protein may make these new-
ly synthesized bipyridine compounds good inhibitors 
of MtbAGPR. Therefore it is pleasing to state that the 
docking studies have widened the scope of the devel-
opment of bipyridine compounds as promising anti-
tuberculosis agents. 
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Compound Hydrogen bond 
Distance (Å) 
D-H…A 
B.E 
(kcal/mol) 
Ia 
  
(ARG 212) N-H…O 
(ARG 218) N-H…O 
N-H…O(ARG 218) 
  
3.7 
2.0 
3.4 
-8.16 
Ib 
  
(ARG 114) N-H…O 
(ARG 114) N-H…O 
N-H…O (PRO 89) 
  
  
2.6 
2.5 
3.8 
  
-7.55 
Table 3. The results of both the compounds docked with the 
enzyme MtbAGPR. 
Figure 6. Monomer of MtbAGPR docked with both com-
pounds (left) and surface view of the binding pocket of the 
bipyridine compounds in MtbAGPR (right). 
have been deposited with the Cambridge Crystallo-
graphic data Centre as supplementary publication 
CCDC 994649 & CCDC 994650. Copies of the data 
can be obtained, free of charge, on application to, 
CCDC, 12 Union Road, Cambridge, and CB2 1 
EZUK;            Fax:  044-1223-336033; Email: depos-
it@ccdc.cam.uk or at: http://www.ccdc.cam.ac.uk/. 
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